ArticleResearch square2025
CD70 drives cSCC growth by linking DNA damage response, inflammation, and tumor-stromal signaling.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
10 authors.
Funding
Abstract
Chronic ultraviolet (UV) exposure drives the development of non-melanoma skin cancers (NMSCs), particularly cutaneous squamous cell carcinoma (cSCC), through persistent DNA damage and inflammation. However, the molecular mediators that link genotoxic stress to tumor-promoting signaling and stromal activation remain poorly defined. Here, we identify CD70, a TNF superfamily member, as a UV- and DNA damage-inducible regulator that coordinates epithelial and stromal responses to promote skin carcinogenesis. Integrative analyses of transcriptomic (GTEx, GSE2503, GSE42677), proteomic (RPPA), and immunostaining datasets revealed marked upregulation of CD70 in sun-exposed skin, actinic keratoses, and cSCC lesions. Functionally, CD70 silencing suppressed cSCC proliferation and xenograft growth, whereas solar UV or DMBA exposure induced CD70 expression. Mechanistically, E2F1 directly bound and activated the CD70 promoter, establishing a transcriptional axis linking the DNA damage response to CD70 upregulation. CD70 depletion disrupted cytokine-receptor and MAPK/NF-κB signaling and altered inflammatory gene expression in UV-irradiated keratinocytes. In dermal fibroblasts, TGF-β-induced CD70 enhanced NF-κB activation and secretion of IL-6 and MCP3, thereby reinforcing paracrine inflammatory loops that supported cSCC spheroid expansion and tumor progression. CD70 knockdown in fibroblasts abrogated these effects and reduced tumor proliferation and cytokine expression in vivo. Collectively, our findings identify CD70 as a stress-inducible signaling hub that links DNA damage, inflammation, and tumor-stromal communication in skin carcinogenesis. Targeting CD70 may disrupt this feed-forward inflammatory circuit and provide a therapeutic strategy for inflammation-driven skin cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.